tirzepatide fort lauderdale $77 For a 4-Week Weight Loss Program W/ Consultation at WeightCare tirzepatide fort lauderdale Tirzepatide (Mounjaro®)

If approved, your medication will be delivered discreetly to your door

Y., Nikolic-Paterson, D

Body Composition Monitoring: We use professional analysis to ensure you are losing fat, not lean muscle, which is vital for maintaining your metabolism

Afrin S, Alashqar A, El Sabeh M, Miyashita-Ishiwata M, Reschke L, Brennan JT, Fader A, Borahay MA

Here's how they compare: Semaglutide (GLP-1 agonist) Mechanism: Single-action GLP-1 receptor agonist FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: 15-20% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients starting their weight loss journey seeking proven, well-studied medication Tirzepatide (dual GIP/GLP-1 agonist) Mechanism: Targets both GIP and GLP-1 receptors for enhanced metabolic effect FDA status: Approved for type 2 diabetes and chronic weight management Expected weight loss: Up to 22% of body weight in clinical trials Administration: Once-weekly injection Best for: Patients seeking more aggressive fat loss with dual-action metabolic support Retatrutide (triple agonist, not yet available) Mechanism: Targets GLP-1, GIP, and glucagon receptors FDA status: Not FDA-approved